Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Structured Use of Ultrasound Scanning for Fetal Growth (Oxford Growth Restriction Identification Programme (OxGRIP)) on Risk Factors for and the Incidences of Adverse Maternal, Fetal and Neonatal Outcome

NCT03662178 is registered in ClinicalTrials.gov with Oxford University Hospitals NHS Trust as lead sponsor.

NCT NCT03662178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03662178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Structured Use of Ultrasound Scanning for Fetal Growth (Oxford Growth Restriction Identification Programme (OxGRIP)) on Risk Factors for and the Incidences of Adverse Maternal, Fetal and Neonatal Outcome
Lead sponsor
Oxford University Hospitals NHS Trust
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2017
Completion date
September 30, 2029
Enrollment
56,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fetal death, fetal growth restriction, fetal growth retardation, intrauterine growth restriction, perinatal death, small for gestational age, stillbirth